(Total Views: 262)
Posted On: 02/13/2018 11:07:15 AM
Post# of 72436
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: daydreaming2 #41923
I understand now! I agree that IPIX is very well positioned and they are doing exactly what they told us they would do....get the indications to the mid-stage clinical trial level and then seek partnerships/licensing/buyouts. I believe this is why additional trials have not been specifically identified in recent PRs and are only discussed in concept for the future when partners are on board. I look forward to upcoming P results and the potential that the 505(2)b designation can provide.....if results are as hoped, this is going to get very interesting!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)